A great day for networking when the BonePain II consortium convenes in lovely Cambridge!
The members of the BonePain II network, a European Innovative Training Network committed to promote research, innovation and education within bone pain, is meeting this week for their annual meeting, this time at AstraZeneca’s Discovery Centre in Cambridge, UK.
During the past three years, the network has brought together academic and industrial partners to provide early-stage researchers with outstanding training and secondments. It will be exciting to see the progress that has been made by the fifteen PhD students and their labs! Cellectricon is represented by Lydia Moll who is conducting her PhD research to develop “disease in a dish” microfluidic co-culture models to study bone and nerve cell interactions and their possible contributions to bone pain.
The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 814244.